These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 19408505

  • 1. Hearing loss and vestibular function correlation in Menière's disease patients.
    Boleas-Aguirre MS, Palomar-Asenjo V, Sánchez-Ferrándiz N, Pérez N.
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):255-8. PubMed ID: 19408505
    [Abstract] [Full Text] [Related]

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 5. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 6. [Vestibular and auditory functions in Ménière's disease].
    Zhang S, Zhao C, Yu L.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996 Sep; 31(3):149-52. PubMed ID: 9639712
    [Abstract] [Full Text] [Related]

  • 7. Saccular dysfunction in Meniere's disease.
    de Waele C, Huy PT, Diard JP, Freyss G, Vidal PP.
    Am J Otol; 1999 Mar; 20(2):223-32. PubMed ID: 10100527
    [Abstract] [Full Text] [Related]

  • 8. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 9. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS, Johnson IJ.
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [Abstract] [Full Text] [Related]

  • 11. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 12. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease.
    Ozluoglu LN, Akkuzu G, Ozgirgin N, Tarhan E.
    Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 14. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S, Dumas G, Morel N, Chahine K, Karkas A.
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [Abstract] [Full Text] [Related]

  • 15. Effects of a single intratympanic gentamicin injection on Meniere's disease.
    Chung WH, Chung KW, Kim JH, Cho YS, Hong SH.
    Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
    Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S.
    Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
    [Abstract] [Full Text] [Related]

  • 17. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS, Lai JT.
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [Abstract] [Full Text] [Related]

  • 19. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S, Chen Z, Yu D, Wu Y, Shi H, Zhou H, Wang J.
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [Abstract] [Full Text] [Related]

  • 20. Implication of vibration induced nystagmus in Meniere's disease.
    Hong SK, Koo JW, Kim JS, Park MH.
    Acta Otolaryngol Suppl; 2007 Oct; (558):128-31. PubMed ID: 17882583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.